pentetic acid has been researched along with Cough in 1 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Cough: A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Higenbottam, T | 1 |
Jackson, M | 1 |
Woolman, P | 1 |
Lowry, R | 1 |
Wallwork, J | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Prospective and Retrospective Study to Develop a Multi-center Randomized Study, to Determine if Prevention of GERD Related Aspiration by Surgical Fundoplication Improves Lung Allograft Function[NCT01406210] | 647 participants (Actual) | Observational | 2011-09-30 | Completed | |||
Investigating the Role of Nebulised Mucolytic Therapy During Lower Respiratory Tract Infections Post Lung Transplantation.[NCT01952470] | Phase 2 | 32 participants (Actual) | Interventional | 2013-10-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
"Self-reported symptom severity, used as a daily patient diary. The BCSS is a 12 point self-reported symptom severity score, consisting of 3 sections concerning how much difficulty the subject is having with breathing; subjective cough symptoms and trouble caused by sputum, each scoring between 0-4, combining to a total score of 0-12 (higher=worse). This scale is validated for daily use in Chronic Obstructive Pulmonary Disease (COPD)(21).~An exacerbation was defined as an increase in BCSS>1 with ≥5 days preceding stability." (NCT01952470)
Timeframe: Daily up to 3 months.
Intervention | Exacerbations (Mean) | |
---|---|---|
Intervention phase | Follow-up phase | |
Dornase Alfa | 0.94 | 2.64 |
Isotonic Saline | 1.07 | 3.62 |
Sputum colour chart. Sputum colour has been shown to correlate with physiological infection in other chronic lung disease groups(22). (NCT01952470)
Timeframe: Daily up to 3 months.
Intervention | days (Median) | |
---|---|---|
Intervention phase | Follow-up phase | |
Dornase Alfa | 11.50 | 4.50 |
Isotonic Saline | 8.50 | 6.00 |
An inflammatory marker measured with routine blood tests on admission with LRTI. Taken during inpatient (IP) stay and routinely on outpatient (OP) follow-up. Existing / available data only will be used - no extra routine bloods will be taken on account of study inclusion. (NCT01952470)
Timeframe: 1 month, 3 months.
Intervention | mg/L (change) (Median) | |
---|---|---|
1 month | 3 months | |
Dornase Alfa | 1.00 | 12 |
Isotonic Saline | 2.50 | 1.00 |
FER represents the proportion of a person's vital capacity that they are able to expire in the first second of forced expiration (FEV1) to the full, forced vital capacity (FVC). (NCT01952470)
Timeframe: 1 month, 3 months
Intervention | Ratio (Mean) | |
---|---|---|
1 month | 3 months | |
Dornase Alfa | 66.33 | 62.79 |
Isotonic Saline | 70.87 | 70.27 |
FEV1 is the maximal amount of air you can forcefully exhale in one second. (NCT01952470)
Timeframe: 1 month, 3 months.
Intervention | Liters (L) - change (Mean) | |
---|---|---|
FEV1 L 1 month | FEV1 L 3 months | |
Dornase Alfa | 2.11 | 1.91 |
Isotonic Saline | 1.76 | 1.78 |
FEV1 is the maximal amount of air you can forcefully exhale in one second. (NCT01952470)
Timeframe: 1 month, 3 months
Intervention | Percent (%) (Mean) | |
---|---|---|
1 month | 3 months | |
Dornase Alfa | 69.33 | 63.00 |
Isotonic Saline | 58.33 | 57.60 |
Forced vital Capacity (FVC) is a measure of the amount of air someone can forcibly expel out of the lungs after taking a breath to fill the lungs as much as possible. (NCT01952470)
Timeframe: 1 month, 3 months
Intervention | Liters (L) (Mean) | |
---|---|---|
1 month | 3 months | |
Dornase Alfa | 3.21 | 2.96 |
Isotonic Saline | 2.46 | 2.50 |
Forced vital Capacity (FVC) is a measure of the amount of air someone can forcibly expel out of the lungs after taking a breath to fill the lungs as much as possible. (NCT01952470)
Timeframe: 1 month, 3 months
Intervention | Percent (%) (Mean) | |
---|---|---|
1 month | 3 months | |
Dornase Alfa | 79.40 | 74.41 |
Isotonic Saline | 62.07 | 63.73 |
Volume of air remaining in the lungs after normal expiration. (NCT01952470)
Timeframe: 1 month, 3 months
Intervention | Liters (L) (Mean) | |
---|---|---|
1 month | 3 months | |
Dornase Alfa | 2.03 | 2.22 |
Isotonic Saline | 1.80 | 1.78 |
Number of days spent in the acute inpatient setting. (NCT01952470)
Timeframe: Across study period (3 months).
Intervention | Days (Mean) | |||
---|---|---|---|---|
All cause - intervention | All cause - follow-up | Respiratory - intervention | Respiratory - follow-up | |
Dornase Alfa | 8.67 | 8.09 | 9.20 | 9.83 |
Isotonic Saline | 12.50 | 11.38 | 21.50 | 14.33 |
Cough specific quality of life questionnaire. The LCQ is a 19-question tool, validated in chronic lung disease other than lung transplant(19). Scale 1-7 for physical, psychological, social. Combined score of 3-21 for total. Lower=worse. (NCT01952470)
Timeframe: 1 month, 3 months.
Intervention | score on a scale (Mean) | |||||||
---|---|---|---|---|---|---|---|---|
Physical 1 month | Physical 3 months | Psychological 1 month | Psychological 3 months | Social 1 month | Social 3 months | Total 1 month | Total 3 months | |
Dornase Alfa | 5.73 | 5.56 | 6.32 | 6.03 | 6.33 | 6.12 | 17.26 | 17.70 |
Isotonic Saline | 5.12 | 5.69 | 5.87 | 6.05 | 5.75 | 6.07 | 16.72 | 17.81 |
"A measure of ventilation inhomogeneity as measured during multiple breath washout (MBW) of inert tracer gases. It has been shown that this test is a potentially more sensitive measure of peripheral airway obstruction than regular spirometry in short term (4 week) mucolytic interventional studies in pediatric Cystic Fibrosis (CF)(17-18). This test would be performed within the respiratory physiology lung function laboratory on site at all assessment points, by an assessor who is blinded to group allocation for follow up data collection.~Conventionally used primary endpoints in this population, such as regular spirometry(3), may be unable to detect between group differences without large sample sizes and long treatment durations. Based on current evidence from non-lung transplant populations, LCI has been able to show short-term change, whereas regular spirometry has not shown change(17-18)." (NCT01952470)
Timeframe: 1 month, 3 months
Intervention | Index (change) (Mean) | |
---|---|---|
1 month | 3 months | |
Dornase Alfa | 10.68 | 10.09 |
Isotonic Saline | 11.65 | 11.19 |
"Multiple breath washout is a sensitive measure of respiratory function performed with the subject in a seated position, breathing a fixed tidal volume (1L) of inert gas (nitrogen) from functional residual capacity (FRC) via mouthpiece.~Two common outcomes of MBW are Sacin, a measure of gas mixing at the diffusion front, or acinar entrance in the airways, and Scond, in the proximal, conductive zones. An increase in either Sacin or Scond represents an increase in ventilation heterogeneity (deterioration). Both increase with age, normal values are non-zero between 0-0.25(Sacin) and 0-0.1(Scond)." (NCT01952470)
Timeframe: 1 month, 3 months
Intervention | Gas mixing index (Sacin / Scond) (Mean) | |||
---|---|---|---|---|
Sacin 1 month | Sacin 3 months | Scond 1 month | Scond 3 months | |
Dornase Alfa | 0.348 | 0.354 | 0.045 | 0.033 |
Isotonic Saline | 0.383 | 0.356 | 0.026 | 0.021 |
Number of admissions to the acute setting. (NCT01952470)
Timeframe: Over study period (3 months).
Intervention | Hospitalizations (Number) | |||
---|---|---|---|---|
All cause - intervention | All cause - follow-up | Respiratory - intervention | Respiratory - follow-up | |
Dornase Alfa | 8 | 12 | 7 | 6 |
Isotonic Saline | 4 | 8 | 2 | 6 |
Antibiotic use for the treatment of lower respiratory tract infections (LRTI) only. (NCT01952470)
Timeframe: Over study period (3 months).
Intervention | Days (Median) | |
---|---|---|
Intervention phase | Follow-up phase | |
Dornase Alfa | 23.50 | 14.00 |
Isotonic Saline | 25.00 | 10.50 |
"The SGRQ is a 2-part questionnaire, validated in chronic lung disease other than lung transplant(20).~50 items, 76 weighted responses. Scores range 0-100, higher=worse." (NCT01952470)
Timeframe: 1 month, 3 months.
Intervention | units on a scale (Mean) | |||||||
---|---|---|---|---|---|---|---|---|
Symptom 1 month | Symptom 3 months | Activity 1 month | Activity 3 months | Impact 1 month | Impact 3 months | Total 1 month | Total 3 months | |
Dornase Alfa | 55.65 | 48.52 | 40.82 | 53.18 | 20.59 | 25.96 | 32.50 | 37.97 |
Isotonic Saline | 61.93 | 51.47 | 57.38 | 53.81 | 30.72 | 33.90 | 43.58 | 40.81 |
1 other study available for pentetic acid and Cough
Article | Year |
---|---|
The cough response to ultrasonically nebulized distilled water in heart-lung transplantation patients.
Topics: Adult; Aerosols; Afferent Pathways; Cough; Denervation; Female; Heart Transplantation; Heart-Lung Tr | 1989 |
The cough response to ultrasonically nebulized distilled water in heart-lung transplantation patients.
Topics: Adult; Aerosols; Afferent Pathways; Cough; Denervation; Female; Heart Transplantation; Heart-Lung Tr | 1989 |
The cough response to ultrasonically nebulized distilled water in heart-lung transplantation patients.
Topics: Adult; Aerosols; Afferent Pathways; Cough; Denervation; Female; Heart Transplantation; Heart-Lung Tr | 1989 |
The cough response to ultrasonically nebulized distilled water in heart-lung transplantation patients.
Topics: Adult; Aerosols; Afferent Pathways; Cough; Denervation; Female; Heart Transplantation; Heart-Lung Tr | 1989 |